Company / Capital Expenditures
UTAH MEDICAL PRODUCTS INC Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$639.0K
FY2025
5-year range
$540.0K / $860.0K
FY2021-FY2025
Trend
-21.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 10 years, ranging from $176,000 in FY2017 to $3M in FY2018.
Based on SEC 10-K filings.
$639,000 in FY2025 with a 5-year CAGR of +9.7%.
Improved from $552,000 to $639,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -9.4%
- 5-Year CAGR
- +9.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +9.7%, indicating consistent growth.
- In FY2025, capital expenditures decreased 21.0% year-over-year.
- Peak capital expenditures was recorded in FY2018.
- Lowest capital expenditures in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $639.0K | -21.0% |
| FY2024 | $809.0K | +46.6% |
| FY2023 | $552.0K | -35.8% |
| FY2022 | $860.0K | +59.3% |
| FY2021 | $540.0K | +34.3% |
| FY2020 | $402.0K | -74.8% |
| FY2019 | $1.6M | -51.5% |
| FY2018 | $3.3M | +1771.0% |
| FY2017 | $176.0K | -84.1% |
| FY2016 | $1.1M | +227.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026